WallStreetZenWallStreetZen

NASDAQ: MOR
Morphosys Ag Stock Forecast, Predictions & Price Target

Analyst price target for MOR

Based on 4 analysts offering 12 month price targets for Morphosys Ag.
Min Forecast
$4.75-73.68%
Avg Forecast
$12.13-32.83%
Max Forecast
$18.25+1.11%

Should I buy or sell MOR stock?

Based on 4 analysts offering ratings for Morphosys Ag.
Buy
Strong Buy
1 analysts 25%
Buy
1 analysts 25%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MOR stock forecasts and price targets.

MOR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-14
lockedlocked$00.00+00.00%2023-12-05
lockedlocked$00.00+00.00%2023-11-22
lockedlocked$00.00+00.00%2023-11-21

1 of 1

Forecast return on equity

Is MOR forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.42%

Forecast return on assets

Is MOR forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MOR revenue forecast

What is MOR's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$250.2M-5.49%
Avg 2 year Forecast
$472.7M+78.52%
Avg 3 year Forecast
$500.4M+89%
MOR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MOR revenue growth forecast

How is MOR forecast to perform vs Biotechnology companies and vs the US market?
Company
28.17%
Industry
37.5%
Market
10.08%
MOR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MOR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MOR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MOR$18.05$12.13-32.83%Buy
MLTX$42.43$77.00+81.48%Strong Buy
ACAD$16.59$30.20+82.03%Buy
ACLX$52.82$79.33+50.20%Strong Buy
ARWR$23.29$49.40+112.11%Buy

Morphosys Ag Stock Forecast FAQ

Is Morphosys Ag Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: MOR) stock is to Buy MOR stock.

Out of 4 analysts, 1 (25%) are recommending MOR as a Strong Buy, 1 (25%) are recommending MOR as a Buy, 2 (50%) are recommending MOR as a Hold, 0 (0%) are recommending MOR as a Sell, and 0 (0%) are recommending MOR as a Strong Sell.

If you're new to stock investing, here's how to buy Morphosys Ag stock.

What is MOR's revenue growth forecast for 2024-2026?

(NASDAQ: MOR) Morphosys Ag's forecast annual revenue growth rate of 28.17% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Morphosys Ag's revenue in 2024 is $258,998,166.On average, 3 Wall Street analysts forecast MOR's revenue for 2024 to be $9,422,068,380, with the lowest MOR revenue forecast at $6,842,314,944, and the highest MOR revenue forecast at $11,282,985,251. On average, 3 Wall Street analysts forecast MOR's revenue for 2025 to be $17,797,700,503, with the lowest MOR revenue forecast at $13,500,119,717, and the highest MOR revenue forecast at $25,829,917,777.

In 2026, MOR is forecast to generate $18,842,065,728 in revenue, with the lowest revenue forecast at $16,997,528,842 and the highest revenue forecast at $20,686,602,614.

What is MOR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MOR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MOR's Price Target?

According to 4 Wall Street analysts that have issued a 1 year MOR price target, the average MOR price target is $12.13, with the highest MOR stock price forecast at $18.25 and the lowest MOR stock price forecast at $4.75.

On average, Wall Street analysts predict that Morphosys Ag's share price could fall to $12.13 by Mar 14, 2025. The average Morphosys Ag stock price prediction forecasts a potential downside of 32.83% from the current MOR share price of $18.05.

What is MOR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MOR) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.